HR 2355
117th Congress
House
Health
Business records
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Health information and medical records
Health personnel
Health programs administration and funding
Photography and imaging
Prescription drugs
Retail and wholesale trades
Opioid Prescription Verification Act of 2021
Introduced: April 5, 2021
See on congress.gov
Everywhere this bill has been
17 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 9, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 8, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 8, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
Dec 8, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422).(consideration: CR H7540-7541)
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 130.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Apr 13, 2021
Referred to the Subcommittee on Health.
Apr 5, 2021
Referred to the House Committee on Energy and Commerce.
Apr 5, 2021
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Dec 9, 2021 | House · vote #422 | On Motion to Suspend the Rules and Pass, as Amended | Passed | 410–15 | See who voted → |
Plain-English summary
Opioid Prescription Verification Act of 2021
This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.
In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that
- maintain a prescription drug monitoring program that mandates the collection of specified information,
- require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
- require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
3